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Introduction {#jcsm12053-sec-0005}
============

Cumulative evidence has shown inverse relationships between estimated glomerular filtration rate (eGFR) and overall and cardiovascular mortality.[1](#jcsm12053-bib-0001){ref-type="ref"}, [2](#jcsm12053-bib-0002){ref-type="ref"} Recent studies have shown a U‐shaped relationship between eGFR and mortality. Intriguingly, high eGFRs are paradoxically associated with increased mortality, particularly in the elderly population.[3](#jcsm12053-bib-0003){ref-type="ref"}, [4](#jcsm12053-bib-0004){ref-type="ref"} However, the reason for this paradox has not been explored.

Experimental and clinical studies have suggested that glomerular hyperfiltration, an early phase of diabetes, is associated with subsequent higher mortality risk.[5](#jcsm12053-bib-0005){ref-type="ref"}, [6](#jcsm12053-bib-0006){ref-type="ref"}, [7](#jcsm12053-bib-0007){ref-type="ref"} However, not all people included in previous studies had diabetes mellitus,[3](#jcsm12053-bib-0003){ref-type="ref"}, [4](#jcsm12053-bib-0004){ref-type="ref"} and the interval between hyperfiltration and the development of catastrophic outcomes is typically long. Therefore, this paradoxical relationship cannot be fully explained by glomerular hyperfiltration. In contrast, low serum creatinine levels in older people with loss of muscle mass may contribute to high eGFR. Malnutrition, chronic inflammation, and cachexia tend to occur concurrently in elderly individuals, which is often termed as 'malnutrition--inflammation--cachexia syndrome' (MICS) or protein‐energy wasting.[8](#jcsm12053-bib-0008){ref-type="ref"}, [9](#jcsm12053-bib-0009){ref-type="ref"}, [10](#jcsm12053-bib-0010){ref-type="ref"} Chronic disease accompanied by MICS could accelerate muscle mass wasting in older people, thereby affecting survival outcomes. Moreover, protein‐energy wasting, a systematically defined condition that reflects malnutrition and wasting resulting from inflammatory and non‐inflammatory conditions, is associated with increased mortality in older patients.[11](#jcsm12053-bib-0011){ref-type="ref"}, [12](#jcsm12053-bib-0012){ref-type="ref"}, [13](#jcsm12053-bib-0013){ref-type="ref"} Several nutritional assessment tools are not only able to measure malnutrition but also detect the presence and severity of inflammation. Therefore, the existence of an overlap between malnutrition and inflammation at both overlapping causes and diagnosis is increasingly acknowledged.[8](#jcsm12053-bib-0008){ref-type="ref"} The Geriatric Nutritional Risk Index (GNRI) has been developed and validated as a simplified assessment tool for evaluating the nutritional status complications in hemodialysis patients and at‐risk elderly individuals.[14](#jcsm12053-bib-0014){ref-type="ref"}, [15](#jcsm12053-bib-0015){ref-type="ref"} It was regarded as a good prognostic predictor of morbidity and mortality for grading the nutritional risk and identifying elderly individuals at risk for MICS. Based on this background, we tested the hypothesis that high eGFR and MICS may be an interactive factor for mortality in a large, well‐characterized cohort of patients using data from the Taipei City Elderly Health Examination Database.

Materials and Methods {#jcsm12053-sec-0006}
=====================

Data source {#jcsm12053-sec-0007}
-----------

In 2001, the Taipei City Government launched an annual Geriatric Health Examination Program for citizens aged ≥65 years. This programme provides health examinations that are performed according to an identical protocol and medical services with no formal referral requirement. Older citizens participate on a voluntary basis, are encouraged to undergo health examination annually, and are free to choose any hospital contracted with the Taipei City Government.[16](#jcsm12053-bib-0016){ref-type="ref"}, [17](#jcsm12053-bib-0017){ref-type="ref"} All participants provide written informed consent authorizing the Taipei City Government Institution to process health examination data and release data for research purposes. This database is linked to the national death registry system. Detailed data are centrally stored in the Taipei City Elderly Health Examination Database and are adequately de‐identified before being released. The institutional review board of the Taipei City Hospital approved this study (TCHIRB‐1010323‐E; TCHIRB‐1030601‐W).

Study design and data collection {#jcsm12053-sec-0008}
--------------------------------

The study cohort comprised participants aged ≥65 years who had undergone at least one serum creatinine measurement between 2001 and 2010. We excluded individuals with histories of end‐stage renal disease or kidney transplant. Sociodemographic and lifestyle‐related data (i.e. age, gender, marital status, education level, alcohol consumption, smoking status, and exercise habit) were collected using a self‐administered questionnaire through the Geriatric Health Examination Program. We also recorded the body height, body weight, systolic and diastolic blood pressure measured at each visit, and participants\' past medical histories of hypertension, diabetes mellitus, dyslipidaemia, coronary artery disease, and cerebrovascular disease. Body mass index (BMI) was calculated using the formula weight (in kilogrammes) / height (in square metres). The following laboratory data were also included in the analysis: white blood cell (WBC) count, dipstick urinalysis results, fasting glucose, and total cholesterol levels, and concentrations of haemoglobin, blood urea nitrogen, creatinine, albumin, uric acid, and triglycerides.

Assessment of malnutrition--inflammation--cachexia syndrome {#jcsm12053-sec-0009}
-----------------------------------------------------------

The GNRI formula used is as follows: GNRI = (1.489 × albumin in grammes per litre) + (41.7 × present/ideal body weight). The ideal body weight was calculated according to the Lorentz formula, which takes into account a patient\'s height and sex: for men, height − 100 − \[(height − 150)/4\]; for women, height − 100 − \[(height − 150)/2.5\]. The presence of MICS in elderly individuals was defined as the presence of at least one of the following conditions: BMI \<22 kg/m^2^, serum albumin \<3.0 mg/dL, or GNRI \<98.[15](#jcsm12053-bib-0015){ref-type="ref"} The participants were categorized into groups according to the presence or absence of MICS to examine the impact of this condition on the outcomes.

Assessment of kidney function {#jcsm12053-sec-0010}
-----------------------------

After an overnight fast, blood was collected, and serum creatinine was analysed using the uncompensated Jaffe method and alkaline picrate kinetic test.[18](#jcsm12053-bib-0018){ref-type="ref"} The eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) equation or the Modification of Diet in Renal Disease (MDRD) Study equation.[19](#jcsm12053-bib-0019){ref-type="ref"} The participants were further classified by the stage of CKD based on their eGFR.

Study outcomes {#jcsm12053-sec-0011}
--------------

Mortality data were obtained from the national death registry system and coded from death certificates according to the *International Classification of Diseases* (ICD)‐9 or ICD‐10. The primary outcome was all‐cause mortality (ICD‐9 001.x--999.x or ICD‐10 A00.x--Z99.x). The secondary outcome was cardiovascular‐related death (ICD‐9 393.x--459.x; ICD‐10 I07.x--I77.x, I99.x, J00.x, and J04.x). All participants were followed up until death or 31 December 2010.

Statistical analysis {#jcsm12053-sec-0012}
--------------------

Descriptive statistics were used to describe the baseline characteristics of the study cohort. Baseline characteristics of the two groups were compared using the Pearson χ^2^ test for categorical variables and the independent *t*‐test for parametric continuous variables. A Cox proportional hazard model was used to calculate adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for the risk of mortality in each group. We further used eGFR linear splines (knots at intervals of 15 mL/min/1.73 m^2^ between 30 and 105 mL/min/1.73 m^2^) in Cox proportional hazard models, providing HRs with eGFR of 80 mL/min/1.73 m^2^ selected as a stable reference for all age categories, based on the research by Hallan *et al*.[20](#jcsm12053-bib-0020){ref-type="ref"} Reference ranges are important for statistical testing, but they do not alter the shape of the association across the full range of exposure. Other covariates included in the models are listed in *Table* [1](#jcsm12053-tbl-0001){ref-type="table-wrap"}. In addition, we conducted further subgroup analysis stratified by sex, age, smoking, diabetes mellitus, hypertension, and dyslipidaemia to explore the interaction between eGFR and mortality in the presence or absence of MICS. We considered an interaction term to be significant by Bonferroni‐corrected alpha levels of 0.008 (0.05/6). All statistical analyses were conducted using STATA statistical software (version 13.0; StataCorp, College Station, TX, USA). A *P* value of \<0.05 was considered to be statistically significant.

###### 

Demographic and clinical characteristics of the study population

  Characteristic                     Overall         With MICS       Without MICS    *P*
  ---------------------------------- --------------- --------------- --------------- ---------
  Number of patients, *N* (%)        131 354 (100)   38 151 (29.0)   93 203 (71.0)   
  Demographic characteristics                                                        
  Age (years)                        72.6 ± 6.3      73.5 ± 6.3      71.6 ± 6.1      \<0.001
  Sex (male), *N* (%)                68 533 (52.1)   19 290 (50.6)   49 243 (52.8)   0.147
  Hypertension, *N* (%)              72 159 (54.9)   16 978 (44.5)   55 181 (59.2)   \<0.001
  Diabetes mellitus, *N* (%)         15 536 (11.8)   3858 (10.1)     11 678 (12.5)   \<0.001
  Dyslipidaemia, *N* (%)             68 408 (52.0)   18 451 (48.4)   49 957 (53.6)   \<0.001
  Coronary artery disease, *N* (%)   15 277 (11.6)   3879 (10.2)     11 398 (12.2)   0.679
  Cerebrovascular disease, *N* (%)   1212 (0.9)      452 (1.2)       760 (0.8)       \<0.001
  Smoking, *N* (%)                   13 332 (10.1)   4265 (11.2)     9067 (9.7)      \<0.001
  Alcohol use, *N* (%)               19 468 (14.8)   4642 (12.2)     14 826 (15.9)   \<0.001
  Systolic blood pressure (mm Hg)    135.7 ± 20.3    132.4 ± 21.0    137.1 ± 19.5    \<0.001
  Diastolic blood pressure (mm Hg)   77.1 ± 12.0     74.7 ± 12.1     78.1 ± 11.7     \<0.001
  eGFR (mL/min/1.73 m^2^)                                                            \<0.001
  ≥90, *N* (%)                       13 187 (10.0)   4254 (11.2)     8933 (9.6)      
  60--89, *N* (%)                    72 631 (55.3)   21 312 (55.9)   51 319 (55.1)   
  30--59, *N* (%)                    42 633 (32.5)   11 444 (30.0)   31 189 (33.5)   
  15--29, *N* (%)                    2199 (1.7)      799 (2.1)       1400 (1.5)      
  \<15, *N* (%)                      704 (0.5)       342 (0.9)       362 (0.4)       
  MICS indicators                                                                    
  Albumin (g/dL)                     4.3 ± 0.3       4.2 ± 0.4       4.4 ± 0.3       \<0.001
  BMI (kg/m^2^)                      24.3 ± 3.5      21.0 ± 2.8      25.6 ± 2.7      \<0.001
  GNRI                               112.7 ± 11.0    104.2 ± 8.4     116.3 ± 10.0    \<0.001
  Other laboratory data                                                              
  WBC count (/mm^3^)                 6100 ± 1,834    5955 ± 2018     6159 ± 1748     \<0.001
  Total cholesterol (mg/dL)          200.1 ± 37.6    197.0 ± 38.6    201.4 ± 37.2    \<0.001
  Triglyceride (mg/dL)               130.0 ± 81.7    122.6 ± 48.0    133.0 ± 55.3    \<0.001
  HDL cholesterol (mg/dL)            53.5 ± 14.7     55.0 ± 10.4     52.9 ± 8.3      \<0.001
  Haemoglobin (g/dL)                 13.5 ± 1.4      13.1 ± 1.5      13.7 ± 1.4      \<0.001
  Uric acid (mg/dL)                  6.1 ± 1.7       5.8 ± 1.7       6.3 ± 1.7       \<0.001
  BUN (mg/dL)                        18.0 ± 6.8      18.1 ± 7.8      17.9 ± 6.3      \<0.001
  Fasting glucose (mg/dL)            107.3 ± 31.1    103.2 ± 29.8    108.9 ± 31.4    \<0.001

Data are presented as *n* (%) or mean ± standard deviation.

BMI, body mass index; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; GNRI, Geriatric Nutritional Risk Index; HDL, high‐density lipoprotein; MICS, malnutrition--inflammation--cachexia syndrome; WBC, white blood cell.

Results {#jcsm12053-sec-0013}
=======

Clinical characteristics of the study population {#jcsm12053-sec-0014}
------------------------------------------------

During the 10‐year study period, a total of 131 354 older participants were identified. Their baseline characteristics are shown in *Table* [1](#jcsm12053-tbl-0001){ref-type="table-wrap"}. The study participants were predominantly male (52.1%), and the mean age was 72.6 years. The most common comorbidities were hypertension (54.9%) and dyslipidaemia (52%). The prevalence rates of smoking and alcohol consumption were 10.1% and 14.8%, respectively. Of the total participants, 38 151 (29.0%) had MICS, and 93 203 (71.0%) did not have MICS. Compared with the participants with MICS, those without MICS were younger and more likely to have diabetes and/or cerebrovascular disease. Participants without MICS also had higher systolic blood pressure, WBC count, total cholesterol level, serum albumin, triglyceride, and haemoglobin concentrations. The detailed numbers of patients with low levels of albumin, BMI, or GNRI were listed in *eTable 1* (see [Supporting Information](#jcsm12053-supinf-0001){ref-type="supplementary-material"}).

Malnutrition--inflammation--cachexia syndrome modified the U‐shaped relationship between estimated glomerular filtration rate and mortality {#jcsm12053-sec-0015}
-------------------------------------------------------------------------------------------------------------------------------------------

The U‐shaped relationship between eGFR and mortality, representing a gradually increased risk of all‐cause mortality, was observed in older participants with eGFR \<60 and ≥90 mL/min/1.73 m^2^ in comparison with those with eGFR of 80 mL/min/1.73 m^2^ (*Figure* [1](#jcsm12053-fig-0001){ref-type="fig"}A).

![Adjusted hazard ratios for all‐cause mortality and cardiovascular mortality according to estimated glomerular filtration rate in all participants (*A* and *D*) in those with (*B* and *E*) and without (*C* and *F*) malnutrition--inflammation--cachexia status. CI, confidence interval; eGFR, estimated glomerular filtration rate; HR, hazard ratio.](JCSM-7-144-g001){#jcsm12053-fig-0001}

In the presence of MICS, the association of eGFR with all‐cause mortality was similar (*Figure* [1](#jcsm12053-fig-0001){ref-type="fig"}B). The exclusion of participants with MICS resulted in the disappearance of the U‐shaped curve between eGFR and mortality and an exponential increase in the risk of all‐cause mortality amongst those with low, but not high, eGFR (*Figure* [1](#jcsm12053-fig-0001){ref-type="fig"}C). Similar associations of eGFR with cardiovascular mortality were noted (*Figure* [1](#jcsm12053-fig-0001){ref-type="fig"}D--F). In the subgroup analyses stratified by MICS parameters, sex and diabetes mellitus, the interaction between MICS and the relationship between eGFR and mortality remained consistent (see [Supporting Information](#jcsm12053-supinf-0001){ref-type="supplementary-material"}, *eFigures 1--5*). The Taipei City Government included the urine dipstick testing in the Geriatric Health Examination Program in 2005. In a stratified analysis of the cohort from 2005 to 2010 that included proteinuria as a categorical variable (negative, trace, 1+, and [\>]{.ul}2+), the interaction between MICS and the association between eGFR and mortality remained consistent (see [Supporting Information](#jcsm12053-supinf-0001){ref-type="supplementary-material"}, *eFigure 6*).

The risk of all‐cause and cardiovascular mortality amongst older adults {#jcsm12053-sec-0016}
-----------------------------------------------------------------------

Using the CKD‐EPI equation, the risk of all‐cause mortality was higher in the groups with eGFR of \<30 mL/min/1.73 m^2^ (aHR, 1.86; 95% CI, 1.72--2.00) and [\>]{.ul} 90 mL/min/1.73 m^2^ (aHR, 1.23; 95% CI, 1.13--1.34) than in those with eGFR of 60--89 mL/min/1.73 m^2^ as the reference group (*Table* [2](#jcsm12053-tbl-0002){ref-type="table-wrap"}). The risk of cardiovascular mortality was also higher in the groups with eGFR of \<30 mL/min/1.73 m^2^ (aHR, 1.87; 95% CI, 1.60--2.19) and ≥90 mL/min/1.73 m^2^ (aHR, 1.28; 95% CI, 1.06--1.54) than in the reference group.

###### 

Risk of all‐cause and cardiovascular mortality amongst older participants

                             Overall             Presence of MICS   Absence of MICS     *P* ~interaction~ [c](#jcsm12053-note-0006){ref-type="fn"}                                 
  -------------------------- ------------------- ------------------ ------------------- ------------------------------------------------------------ ------------------- --------- ---------
  All‐cause mortality                                                                                                                                                              
  ≥90                        1.23 (1.13--1.34)   \<0.001            1.36 (1.21--1.53)   \<0.001                                                      0.71 (0.62--0.80)   \<0.001   \<0.001
  60--89                     1 (reference)       1 (reference)      1 (reference)                                                                                                  
  30--59                     1.17 (1.13--1.21)   \<0.001            1.09 (1.03--1.15)   0.001                                                        1.55 (1.48--1.61)   \<0.001   
  \<30                       1.86 (1.72--2.00)   \<0.001            1.73 (1.55--1.94)   \<0.001                                                      2.53 (2.28--2.81)   \<0.001   
  Cardiovascular mortality                                                                                                                                                         
  ≥90                        1.28 (1.06--1.54)   0.010              1.52 (1.18--1.96)   0.001                                                        0.65 (0.49--0.85)   0.002     \<0.001
  60--89                     1 (reference)       1 (reference)      1 (reference)                                                                                                  
  30--59                     1.30 (1.21--1.39)   \<0.001            1.23 (1.11--1.38)   \<0.001                                                      1.72 (1.58--1.88)   0.094     
  \<30                       1.87 (1.60--2.19)   \<0.001            1.66 (1.30--2.12)   \<0.001                                                      2.71 (2.21--3.33)   \<0.001   

eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD‐EPI) equation.

Adjusted for age, sex, smoking and alcohol habits, systolic and diastolic blood pressure, hypertension, diabetes mellitus, dyslipidaemia, coronary artery disease, cerebrovascular disease, body mass index, white blood cell count, and total cholesterol, triglyceride, high‐density lipoprotein, haemoglobin, uric acid, blood urea nitrogen, fasting glucose, and albumin levels.

*P* ~interaction~ values represent the modifying effect of malnutrition--inflammation--cachexia status on the risk relationship between baseline eGFR and mortality. Values were obtained using Cox models with eGFR serving as a categorical variable.

CI, confidence interval; eGFR, estimated glomerular filtration rate; HR, hazard ratio; MICS, malnutrition--inflammation--cachexia syndrome.

Malnutrition--inflammation--cachexia syndrome and its correlates in older adults {#jcsm12053-sec-0017}
--------------------------------------------------------------------------------

In the presence of MICS, eGFR of [\>]{.ul}90 mL/min/1.73 m^2^ remained associated with an increased risk of all‐cause mortality (aHR, 1.36; 95% CI, 1.21--1.53) and cardiovascular mortality (aHR, 1.52; 95% CI, 1.18--1.96) compared with the reference eGFR of 60--89 mL/min/1.73 m^2^ (*Table* [2](#jcsm12053-tbl-0002){ref-type="table-wrap"}). In the absence of MICS, however, the association of high eGFR with an increased risk of mortality disappeared. In contrast, eGFR of [\>]{.ul}90 mL/min/1.73 m^2^ was associated with a lower risk of all‐cause mortality (aHR, 0.71; 95% CI, 0.62--0.80). These results remained similar after adjusting for BMI alone (see [Supporting information](#jcsm12053-supinf-0001){ref-type="supplementary-material"}, eTable 2). We performed another analysis using MDRD equation to calculate eGFR, and the results remain similar (see [Supporting Information](#jcsm12053-supinf-0001){ref-type="supplementary-material"}, *eTable 3*). In the subgroup analyses, the risk of mortality was increased in older subjects with high eGFR in the presence of MICS, and the results were almost entirely consistent across all subgroups (*Figure* [2](#jcsm12053-fig-0002){ref-type="fig"}). Conversely, in the absence of MICS, the risk of mortality was lower in the high eGFR group than in the reference eGFR group.

![Subgroup analysis of the association between high estimated glomerular filtration rate (\>90 mL/min/1.73 m^2^) and risk of all‐cause mortality as compared with the median estimated glomerular filtration rate (60--89 mL/min/1.73 m^2^) in older participants with malnutrition--inflammation--cachexia status (left panel) and without malnutrition--inflammation--cachexia status (right panel). CI, confidence interval; HR, hazard ratio; MICS, malnutrition--inflammation--cachexia status.](JCSM-7-144-g002){#jcsm12053-fig-0002}

Discussion {#jcsm12053-sec-0018}
==========

Previous large collaborative meta‐analyses have shown that the association between eGFR and mortality forms a U‐shaped curve with an increased risk associated with lower and higher eGFRs, particularly in older people.[4](#jcsm12053-bib-0004){ref-type="ref"}, [20](#jcsm12053-bib-0020){ref-type="ref"}, [21](#jcsm12053-bib-0021){ref-type="ref"} A pooled analysis of community‐based studies found that patients with CKD and eGFR of \<60 mL/min/1.73 m^2^ had a greater risk of all‐cause mortality.[22](#jcsm12053-bib-0022){ref-type="ref"} Several studies have further shown an exponential increase in the mortality rate with declining eGFR, with a sharp increase in eGFR to \<45 mL/min/1.73 m^2^.[1](#jcsm12053-bib-0001){ref-type="ref"} However, the reason underlying this paradoxical association of higher eGFR with mortality has not been thoroughly explored. Cox *et al*.[3](#jcsm12053-bib-0003){ref-type="ref"} have noted that respiratory disease and cancer, rather than cardiovascular disease, were the main causes of death in subjects with high eGFR. Similarly, Tonelli *et al*.[4](#jcsm12053-bib-0004){ref-type="ref"} have suggested that cardiovascular mortality is not the only explanation for death in these subjects. Our study revealed that the increased risk of mortality in subjects with high eGFR was primarily attributable to the presence of MICS, regardless of respiratory disease, cancer, or cardiovascular disease. In the absence of MICS, the U‐shaped relationship between eGFR and mortality disappeared. To our knowledge, these results demonstrate for the first time that MICS could modify the relationship between high eGFR and mortality in older people and that the all‐cause mortality risk did not increase exponentially in subjects with high eGFR in the absence of MICS.

A multicentre trial including 8941 patients with a history of atherosclerotic vascular disease found that high eGFR was associated with an increased risk of adverse cardiovascular outcomes.[23](#jcsm12053-bib-0023){ref-type="ref"} In contrast, another population‐based study found no association between myocardial infarction and higher eGFR, except in subjects with severe proteinuria.[4](#jcsm12053-bib-0004){ref-type="ref"} However, the latter study may be limited by an unbalanced distribution of age, as subjects in the low eGFR group were much older than those in the high eGFR group (mean age, 74.7 vs. 34.1 years). In the present study, all participants were aged ≥65 years. We found that high eGFR was associated with an increased risk of cardiovascular death in the presence but not absence of MICS. Thus, we suggest that older people with high eGFR and MICS remain at risk for adverse cardiovascular outcomes.

Previous studies found that diabetic hyperfiltration was associated with an increased risk of mortality amongst patients with type 1 and type 2 diabetes.[5](#jcsm12053-bib-0005){ref-type="ref"}, [6](#jcsm12053-bib-0006){ref-type="ref"}, [7](#jcsm12053-bib-0007){ref-type="ref"} However, in our study, high eGFR was associated with increased risks of overall and cardiovascular mortality, even in the absence of diabetes mellitus. Thus, glomerular hyperfiltration may not be the primary explanation for the paradoxical association between high eGFR and mortality. The mechanisms underlying the effect of MICS on mortality in older people with high eGFR may include sarcopenia (age‐related loss of muscle mass and strength), which contributes to increase the mortality and illness;[24](#jcsm12053-bib-0024){ref-type="ref"} underweight status, which can affect the immune responses, leading to long‐lasting inflammatory response and increased vulnerability to disease development;[25](#jcsm12053-bib-0025){ref-type="ref"} and malnutrition, which also profoundly affects the immune response and increases frailty, enforcing the vicious cycle of muscle wasting and negatively impacting survival.[26](#jcsm12053-bib-0026){ref-type="ref"}

This study has strengths as follows. First, data for the cohort of 131 354 older participants covering the 10‐year study period were retrieved from the Taipei Geriatric Health Examination Database, providing adequate statistical power for the analysis of long‐term outcomes, including all‐cause and cardiovascular mortality. Second, as the impact of the U‐shaped relationship between eGFR and mortality seems to be more apparent in older than in younger patients,[4](#jcsm12053-bib-0004){ref-type="ref"}, [20](#jcsm12053-bib-0020){ref-type="ref"} we targeted a general population of older individuals who underwent routine health examinations. Some potential limitations of the present study should be acknowledged. First, we did not consider proinflammatory biomarkers, such as C‐reactive protein, interleukins, and cytokines, because their xmeasurement requires sophisticated and expensive techniques that are not feasible in the context of routine health examinations or in a large epidemiological study. Second, sarcopenia has been associated with increased mortality and numerous adverse outcomes,[27](#jcsm12053-bib-0027){ref-type="ref"}, [28](#jcsm12053-bib-0028){ref-type="ref"} but it cannot be accurately evaluated using BMI because fat and muscle mass cannot be readily distinguished. Dual energy X‐ray absorptiometry and bioimpedance analysis may be better for the evaluation of sarcopenia in older people with MICS, but further research is warranted.[29](#jcsm12053-bib-0029){ref-type="ref"}, [30](#jcsm12053-bib-0030){ref-type="ref"}

Our study demonstrated that the paradoxical U‐shaped relationship between high eGFR and mortality was due to the presence of MICS in older people. In the absence of MICS, low (rather than high) eGFR was strongly associated with increased risks of overall and cardiovascular mortality. We thus recommend that physicians closely monitor older people with high eGFR and screen for MICS, particularly in subjects with very low serum creatinine and high eGFR levels.
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**eFigure 2.** Adjusted Hazard Ratios for All‐Cause Mortality According to Estimated Glomerular Filtration Rate in Older Men (A), in Those with (B) and without (C) Malnutrition‐Inflammation‐Cachexia Status Syndrome. Abbreviation: HR, hazard ratio.

**eFigure 3.** Adjusted Hazard Ratios for All‐Cause Mortality According to Estimated Glomerular Filtration Rate in Older Women (A), in Those with (B) and without (C) Malnutrition‐Inflammation‐Cachexia Status Syndrome. Abbreviation: HR, hazard ratio.

**eFigure 4.** Adjusted Hazard Ratios for All‐Cause Mortality According to Estimated Glomerular Filtration Rate in Older Participants with Diabetes Mellitus (A), in Those with (B) and without (C) Malnutrition‐Inflammation‐Cachexia Status Syndrome. Abbreviation: HR, hazard ratio.

**eFigure 5.** Adjusted Hazard Ratios for All‐Cause Mortality Rates According to Estimated Glomerular Filtration Rate in Older Participants without Diabetes Mellitus (A), in Those with (B) and without (C) Malnutrition‐Inflammation‐Cachexia Status Syndrome. Abbreviation: HR, hazard ratio.

**eFigure 6.** Adjusted Hazard Ratios for All‐Cause Mortality Rates According to Estimated Glomerular Filtration Rate in Older Participants with Proteinuria (A), in Those with (B) and without (C) Malnutrition‐Inflammation‐Cachexia Status Syndrome. Abbreviation: HR, hazard ratio.

###### 

Supporting info item

###### 

Click here for additional data file.

[^1]: Shuo‐Ming Ou and Yung‐Tai Chen contributed equally to this study
